NF-κB Activation in T Helper 17 Cell Differentiation

키워드

참고문헌 (63)

1. Hayden, M. S., "Signaling to NF-kappaB", Genes Dev, 18, pp.2195~2224 (2004)
2. Hayden, M. S, "NF-kappaB in immunobiology", Cell Res, 21, pp.223~244 (2011)
3. Hayden, M. S., "NF-kappaB and the immune response", Oncogene, 25, pp.6758~6780 (2006)
4. Schulze-Luehrmann, J., "Antigen-receptor signaling to nuclear factor kappa B", Immunity, 25, pp.701~715 (2006)
5. Oh, H., "NF-kappaB: roles and regulation in different CD4(＋) T-cell subsets", Immunol. Rev, 252, pp.41~51 (2013)
6. Alegre, M. L., "T-cell regulation by CD28 and CTLA-4", Nat. Rev. Immunol, 1, pp.220~228 (2001)
7. Kane, L. P., "It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation", Trends Immunol, 23, pp.413~420 (2002)
8. Frauwirth, K. A., "The CD28 signaling pathway regulates glucose metabolism", Immunity, 16, pp.769~777 (2002)
9. Pages, F., "Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling", Nature, 369, pp.327~329 (1994)
10. Pagan, A. J., "CD28 promotes CD4＋ T cell clonal expansion during infection independently of its YMNM and PYAP motifs", J. Immunol, 189, pp.2909~2917 (2012)
11. Sanchez-Lockhart, M., "Cutting edge: CD28-mediated transcriptional and posttranscriptional regulation of IL-2 expression are controlled through different signaling pathways", J. Immunol, 173, pp.7120~7124 (2004)
12. Yokosuka, T., "Spatiotemporal regulation of T cell costimulation by TCR-CD28 microclusters and protein kinase C theta translocation", Immunity, 29, pp.589~601 (2008)
13. Park, S. G., "The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-kappaB and activate T cells", Nat. Immunol, 10, pp.158~166 (2009)
14. Narayan, P., "CARMA1 is required for Akt-mediated NF-kappaB activation in T cells", Mol. Cell. Biol, 26, pp.2327~2336 (2006)
15. Matsumoto, R., "Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation", Immunity, 23, pp.575~585 (2005)
16. Garcon, F., "CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85", p110 heterodimer, 2008, pp.111, 1464~1471
17. Dodson, L. F., "Targeted knock-in mice expressing mutations of CD28 reveal an essential pathway for costimulation", Mol Cell Biol, 29, pp.3710~3721 (2009)
18. in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C, "J. Cell Biol", 2002, 253~263
19. Kang, J. A., "Transition from heterotypic to homotypic PDK1 homodimerization is essential for TCR-mediated NF-kappaB activation", J. Immunol, 190, pp.4508~4515 (2013)
20. Chuang, H. C., "The kinase GLK controls autoimmunity and NF-kappaB signaling by activating the kinase PKC-theta in T cells", Nat. Immunol, 12, pp.1113~1118 (2011)
21. Romagnani, S., "Lymphokine production by human T cells in disease states", Annu. Rev. Immunol, 12, pp.227~257 (1994)
22. Korn, T., "IL-17 and Th17 Cells", Annu. Rev. Immunol, 27, pp.485~517 (2009)
23. Ahern, P. P., "The interleukin-23 axis in intestinal inflammation", Immunol. Rev, 226, pp.147~159 (2008)
24. Cua, D. J., "Innate IL-17-producing cells: the sentinels of the immune system", Nat. Rev. Immunol, 10, pp.479~489 (2010)
25. Laurence, A., "T(H)-17 differentiation: of mice and men", Nat. Immunol, 8, pp.903~905 (2007)
26. Acosta-Rodriguez, E. V., "Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells", Nat. Immunol, 8, pp.942~949 (2007)
27. Chen, Z., "Distinct regulation of interleukin-17 in human T helper lymphocytes", Arthritis Rheum, 56, pp.2936~2946 (2007)
28. Harrington, L. E., "Interleukin 17-producing CD4＋ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages", Nat. Immunol, 6, pp.1123~1132 (2005)
29. Park, H., "A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17", Nat. Immunol, 6, pp.1133~1141 (2005)
30. Littman, D. R., "Th17 and regulatory T cells in mediating and restraining inflammation", Cell, 140, pp.845~858 (2010)
31. El-Behi, M., "The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF", Nat. Immunol, 12, pp.568~575 (2011)
32. Cooke, A., "Th17 cells in inflammatory conditions", Rev. Diabet. Stud, 3, pp.72~75 (2006)
33. Kramer, J. M., "Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy", J. Periodontol, 78, pp.1083~1093 (2007)
34. Kaser, A., "Inflammatory bowel disease", Annu. Rev. Immunol, 28, pp.573~621 (2010)
35. Chebotar, I. V., "IgG- and C3-dependent adhesion of neutrophils in systems with allogeneic and xenogeneic ligands", Biull. Eksp. Biol. Med, 112, pp.403~404 (1991)
36. Xavier, R. J., "Unravelling the pathogenesis of inflammatory bowel disease", Nature, 448, pp.427~434 (2007)
37. Zhou, L., "IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways", Nat. Immunol, 8, pp.967~974 (2007)
38. Dong, C., "TH17 cells in development: an updated view of their molecular identity and genetic programming", Nat. Rev. Immunol, 8, pp.337~348 (2008)
39. Kobayashi, T., "IL23 differentially regulates the Th1", Th17 balance in ulcerative colitis and Crohn's disease, 2008, pp.57, 1682~1689
40. Fujino, S., "Increased expression of interleukin 17 in inflammatory bowel disease", Gut, 52, pp.65~70 (2003)
41. Zhang, Z., "Critical role of IL-17 receptor signaling in acute TNBS-induced colitis", Inflamm. Bowel Dis, 12, pp.382~388 (2006)
42. Park, S. G., "T regulatory cells maintain intestinal homeostasis by suppressing gammadelta T cells", Immunity, 33, pp.791~803 (2010)
43. Kotake, S., "IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis", J. Clin. Invest, 103, pp.1345~1352 (1999)
44. Wong, C. K., "Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma", Clin. Exp. Immunol, 125, pp.177~183 (2001)
45. Wong, C. K., "Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity", Clin. Immunol, 127, pp.385~393 (2008)
46. Kim, S. W., "Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease", Gut, 60, pp.1527~1536 (2011)
47. Glas, J., "Novel genetic risk markers for ulcerative colitis in the IL2", IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease, 2009, pp.104, 1737~1744
48. Monteleone, G., "Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease", Gastroenterology, 128, pp.687~694 (2005)
49. Sarra, M., "Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases", Inflamm. Bowel Dis, 16, pp.1332~1339 (2010)
50. Stolfi, C., "Pallone, and G. Monteleone. 2011. Involvement of interleukin-21 in the regulation of colitis-associated colon cancer", J. Exp. Med, 208, pp.2279~2290 (2011)
51. Ouaaz, F., "Dendritic cell development and survival require distinct NF-kappaB subunits", Immunity, 16, pp.257~270 (2002)
52. O'Keeffe, M., "Distinct roles for the NF-kappaB1 and c-Rel transcription factors in the differentiation and survival of plasmacytoid and conventional dendritic cells activated by TLR-9 signals", Blood, 106, pp.3457~3464 (2005)
53. Gerondakis, S., "Roles of the NF-kappaB pathway in lymphocyte development and function", Cold Spring Harb. Perspect. Biol, 2, pp.a000182~ (2010)
54. Khayrullina, T., "In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12", IL-23 balance and promotes differentiation of Th17 cells, 2008, pp.181, 721~735
55. Ruan, Q., "The Th17 immune response is controlled by the Rel-RORgamma-RORgamma T transcriptional axis", J. Exp. Med, 208, pp.2321~2333 (2011)
56. Kwon, M. J., "Protein kinase C-theta promotes Th17 differentiation via upregulation of Stat3", J. Immunol, 188, pp.5887~5897 (2012)
57. Brustle, A., "The NF-kappaB regulator MALT1 determines the encephalitogenic potential of Th17 cells", J. Clin. Invest, 122, pp.4698~4709 (2012)
58. Molinero, L. L., "T cell receptor", CARMA1, Pro. Natl. Acad. Sci. USA, pp.2012, 109[DOI]
59. Iguchi-Hashimoto, M., "Overexpression of a minimal domain of calpastatin suppresses IL-6 production and Th17 development via reduced NF-kappaB and increased STAT5 signals", PloS one, 6, pp.e27020~ (2011)
60. Okamoto, K., "IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors", Nature, 464, pp.1381~1385 (2010)
61. Stockinger, B, "Good for Goose, but not for Gander: IL-2 interferes with Th17 differentiation", Immunity, 26, pp.278~279 (2007)
62. Visekruna, A., "c-Rel is crucial for the induction of Foxp3(＋) regulatory CD4(＋) T cells but not T(H)17 cells", Eur. J. Immunol, 40, pp.671~676 (2010)
63. Liu, X., "USP18 inhibits NF-kappaB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex", J. Exp. Med, 210, pp.1575~1590 (2013)

관련 논문AI추천